The company will handle engineering services for the reactor’s conceptual design, including key structures, systems, and ...

Alongside its results, the company announced a significant product launch. On August 11, Pfizer rolled out its ...

Standalone profit after tax was reported at ₹2,046 Crore, higher by 90% against the previous corresponding quarter.

The contract is valued at ₹90.65 crore and will be executed over a period of 18 months under general contract conditions.

Compared to the May survey, the July survey shows household perception of current inflation down 50 bps from 7.7% to 7.2%.

The partnership is part of Infosys’ broader plan to guide clients through every stage of their AI adoption journey.

The CCPS will be converted into equity shares of ABDFVL as per the conversion terms defined in the shareholders’ agreement.

Zydus Lifesciences Ltd said on August 13 that the US Food and Drug Administration (USFDA) has wrapped up a surveillance inspection at its formulation manufacturing plant in Baddi, Himachal Pradesh.

The business said that its revenue for the quarter jumped as much as 66% to ₹3,365 Crore against the previous corresponding ...

The company announced an EBITDA of ₹206 Crore. This was down by 4.6% against the same quarter of previous year.

In July 2025, passive funds saw better traction in flows but strong price depletion.

The company has filed its draft red herring prospectus (DRHP) with the SEBI for an initial public offering valued at ₹4,900 ...